Kellaway Simon C, Roberton Victoria, Jones Joshua N, Loczenski Rabea, Phillips James B, White Lisa J
Centre for Nerve Engineering, University College London, UK; Division of Regenerative Medicine and Cellular Therapies, School of Pharmacy, Biodiscovery Institute, University of Nottingham, University Park, Nottingham, NG7 2RD, UK; Department of Pharmacology, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; Biodiscovery Institute, University of Nottingham, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Centre for Nerve Engineering, University College London, UK; Department of Pharmacology, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Acta Biomater. 2023 Feb;157:124-136. doi: 10.1016/j.actbio.2022.12.003. Epub 2022 Dec 7.
Engineered neural tissue (EngNT) promotes in vivo axonal regeneration. Decellularised materials (dECM) are complex biologic scaffolds that can improve the cellular environment and also encourage positive tissue remodelling in vivo. We hypothesised that we could incorporate a hydrogel derived from a decellularised tissue (dECMh) into EngNT, thereby providing an alternative to the currently used purified collagen I hydrogel for the first time. Decellularisation was carried out on bone (B-ECM), liver (LIV-ECM), and small intestinal (SIS-ECM) tissues and the resultant dECM was biochemically and mechanically characterised. dECMh differed in mechanical and biochemical properties that likely had an effect on Schwann cell behaviour observed in metabolic activity and contraction profiles. Cellular alignment was observed in tethered moulds within the B-ECM and SIS-ECM derived hydrogels only. No difference was observed in dorsal root ganglia (DRG) neurite extension between the dECMh groups and collagen I groups when applied as a coverslip coating, however, when DRG were seeded atop EngNT constructs, only the B-ECM derived EngNT performed similarly to collagen I derived EngNT. B-ECM EngNT further exhibited similar axonal regeneration to collagen I EngNT in a 10 mm gap rat sciatic nerve injury model after 4 weeks. Our results have shown that various dECMh can be utilised to produce EngNT that can promote neurite extension in vitro and axonal regeneration in vivo. STATEMENT OF SIGNIFICANCE: Nerve autografts are undesirable due to the sacrifice of a patient's own nerve tissue to repair injuries. Engineered neural tissue (EngNT) is a type of living artificial tissue that has been developed to overcome this. To date, only a collagen hydrogel has been shown to be effective in the production and utilisation of EngNT in animal models. Hydrogels may be made from decellularised extracellular matrix derived from many tissues. In this study we showed that hydrogels from various tissues may be used to create EngNT and one was shown to comparable to the currently used collagen based EngNT in a rat sciatic nerve injry model.
工程化神经组织(EngNT)可促进体内轴突再生。脱细胞材料(dECM)是复杂的生物支架,可改善细胞环境并促进体内积极的组织重塑。我们假设可以将源自脱细胞组织的水凝胶(dECMh)整合到EngNT中,从而首次为当前使用的纯化I型胶原水凝胶提供替代方案。对骨(B-ECM)、肝(LIV-ECM)和小肠(SIS-ECM)组织进行脱细胞处理,并对所得的dECM进行生化和力学表征。dECMh在力学和生化特性上存在差异,这可能对在代谢活性和收缩曲线中观察到的雪旺细胞行为产生影响。仅在源自B-ECM和SIS-ECM的水凝胶中的束缚模具中观察到细胞排列。当用作盖玻片涂层时,dECMh组和I型胶原组之间在背根神经节(DRG)神经突延伸方面未观察到差异,然而,当将DRG接种在EngNT构建体顶部时,只有源自B-ECM的EngNT表现与源自I型胶原的EngNT相似。在大鼠坐骨神经10毫米间隙损伤模型中,4周后B-ECM EngNT进一步表现出与I型胶原EngNT相似的轴突再生。我们的结果表明,各种dECMh可用于生产能够在体外促进神经突延伸和在体内促进轴突再生的EngNT。重要性声明:由于牺牲患者自身神经组织来修复损伤以进行神经自体移植并不可取。工程化神经组织(EngNT)是一种为克服这一问题而开发的活的人工组织。迄今为止,在动物模型中,仅I型胶原水凝胶已被证明在EngNT的生产和应用中有效。水凝胶可由源自许多组织的脱细胞细胞外基质制成。在本研究中,我们表明来自各种组织的水凝胶可用于创建EngNT,并且在大鼠坐骨神经损伤模型中,其中一种水凝胶显示出与当前使用的基于胶原的EngNT相当。